CNBX News and Press, Cannabics Pharmaceuticals Inc From 06/07/19

The following slide deck was published by Cannabics Pharmaceuticals Inc. in conjunction with this Read more ...

TEL AVIV, Israel and BETHESDA, Maryland , June 4, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it will be participating at the LIFT & Co. Conference at th...

TEL AVIV, Israel and BETHESDA, Maryland , May 30, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it will be presenting at the 9 th annual LD Micro In...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The U.S. will send a high-level delegation to Beijing next week as trade negotiatio...

TEL AVIV, Israel and BETHESDA, Maryland , April 25, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced that Mr. Eyal Barad , CEO, is scheduled to present at the Planet Microc...

Editor's note: This is a transcript version of our recent podcast on Cannabics Pharmaceuticals ( OTCQB:CNBX ). Listen to or subscribe to The Cannabis Investing Podcast on Libsyn , SoundCloud or Apple Podcasts/iTunes . Introduction Rena Sherbill : Jona...

By Rena Sherbill Jonathan Liss and I covered the CannaTech conference in Tel Aviv that ran from April 1 to 2. We talked with a wide variety of attendees and presenters - from executives and scientists to venture capitalists, money managers, marketers and journalists. We'll be ...

TEL AVIV , Israel and BETHESDA, Maryland , April 17, 2019 /PRNewswire/ -- Cannabics Pharmaceuticals Inc.   (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, today announced that it has obtained approval for a...

Editor's note: This is a transcript version of our recent podcast on Cannabics Pharmaceuticals (CNBX). Listen to or subscribe to The Cannabis Investing Podcast on Libsyn , SoundCloud or Apple Podcasts/iTunes . Introduction Rena Sherbill: Jonathan Liss and...